ClinicalTrials HQ

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of Age

Active, not recruiting · NCT05992935 · Registry updated 2026-04-03
Ask about research services

Clinical trials

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Study to Evaluate the Safety, Reactogenicity, and Immunogenicity of mRNA-1403 and mRNA-1405 to Prevent Norovirus Acute Gastroenteritis in Healthy Adults 18 to 80 Years of AgeNorovirus Acute GastroenteritisActive, not recruitingPhase 1 / Phase 22026-04-03NCT05992935

1 results · Page 1 of 1

Organizations

Swipe the table sideways for more columns.

OrganizationsLinked trials
ModernaTX, Inc.41

15 results · Page 1 of 1

Research sites

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Ark Clinical Research, LLCLong BeachUnited States3
Emeritus Research CamberwellCamberwellAustralia1
Epic Medical Research, LLCRed OakUnited States1
JBR Clinical ResearchSalt Lake CityUnited States8
Johnson County Clin-Trials (JCCT)LenexaUnited States3
Nucleus NetworkMelbourneAustralia5
Optimal ResearchPeoriaUnited States3
Research Centers of AmericaHollywoodUnited States14
Rochester Clinical Research, IncRochesterUnited States6
Tekton Research, Inc - Longmont CenterLongmontUnited States2
Velocity Clinical ResearchOmahaUnited States6
Velocity Clinical ResearchNorfolkUnited States4
Velocity Clinical ResearchSioux CityUnited States3
Velocity Clinical ResearchRockvilleUnited States3
Velocity Clinical Research - BoiseMeridianUnited States8